Related Experiment Video
Updated: Aug 13, 2026
Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing
Published on: January 10, 2025
Entonox as an analgesic agent during panretinal photocoagulation
H L Cook1, R S B Newsom, E Mensah
1Department of Ophthalmology, St Thomas's Hospital, London, UK. HelenLCook@aol.com
Background/Aims:
Panretinal photocoagulation (PRP) reduces the risk of visual loss in proliferative diabetic retinopathy but some patients cannot tolerate PRP because of pain. Inhaled Entonox was evaluated as an analgesic during PRP.
Methods:
A randomised, crossover, double masked pilot study was performed. Patients inhaled either air or Entonox and half the PRP was applied. The treatment was completed with the alternate inhaled gas. Patients graded pain experienced during both stages of the treatment using a visual analogue scale. Pain scores were compared using a paired t test.
Results:
20 patients participated. Mean pain scores from the Entonox and air treatments were 2.94 (SD 2.73) versus 3.73 (SD 3.20) respectively (p<0.03).
Conclusion:
Entonox can be used as a safe and effective analgesic agent during PRP treatment.
